PLX stock news

Back in December 2017, Leaprate reported that the SEC obtained an emergency asset freeze to stop the ICO fraud of PlexCorps that raised $15 million from Read more
The Securities and Exchange Commission (SEC) of the US asked the court for permission to distribute over $1.4 million to PlexCoin victims. Read more
CARMIEL, Israel, Dec. 9, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant… Read more
CARMIEL, Israel, Nov. 18, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant… Read more
CARMIEL, Israel, Oct. 29, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant… Read more
Protalix Biotherapeutics, Inc. (NYSEMKT:PLX) Q1 2019 Earnings Conference Call May 06, 2019, 08:30 ET Company Participants Yossi Maimon - CFO, VP, Treasurer &amp Read more
Zacks Investment Research cut shares of Protalix Biotherapeutics (NYSEAMERICAN:PLX) from a buy rating to a hold rating in a research note released on Wednesday. According to Zacks, “Protalix is a bi Read more
Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) traded down 10.9% during trading on Monday . The company traded as low as $0.40 and last traded at $0.41. 1,976,434 shares traded hands during mid-day t Read more
Protalix Biotherapeutics (NYSEAMERICAN:PLX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday. The brokerage currently has Read more
Among 3 analysts covering Polar Capital Holdings PLC (LON:POLR), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Polar Capital Holdings PLC had 10 analyst reports since October 4, 2 Read more
Plexure Group Ltd (PLX.NZ)’s closing price of $0.34 has closed above it’s Parabolic SAR reading, indicating a potential trend reversal. Parabolic SAR (or PSAR) is a simple, compact indicator that Read more
After a recent check, we have noted that Protalix Biotherapeutics (PLX) shares have dropped -8.75% lower over the past 4-weeks. Checking on performance over the last 5 trading days, shares have change Read more
Zooming in on shares of Plexure Group Ltd (PLX.NZ) we have seen that the stock price has gained 6.25% over the last 4-weeks. If we look back over the last half-year, we can see that the stock has move Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT